22/11/2023
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
November 2023
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Oct
Dec »
22/11/2023
Nov 22, 2023, 03:25 |
Blog
The application is open for Cohort 3 of the Robert A. Winn Clinical Investigator Pathway Program (Winn CIPP) - Winn Awards
Winn Awards shared on X/Twitter: ''The application is open for Cohort 3 of the Robert…
Nov 22, 2023, 03:19 |
Insight
Monica Bertagnolli: There has never been more potential for scientific progress!
Quoting Monica Bertagnolli on X/Twitter: "The more I learn during my first few days as the…
Nov 22, 2023, 03:11 |
Blog
Matt Dun: Such inspiring brain cancer research
Matt Dun, Research Fellow at the School of Biomedical Sciences and Pharmacy, shared on X/Twitter:…
Nov 22, 2023, 03:04 |
Drugs
Maria Natalia Gandur Quiroga: Promising results for zanzalintinib in advanced clear cell renal cell carcinoma treatment presented by Sumanta K. Pal
Quoting Maria Natalia Gandur Quiroga on X/Twitter: "Exciting updates from The Kidney Cancer Association's International…
Nov 22, 2023, 02:57 |
Opinion
Ashley Love Sumrall: Must reads and often quoted at our tumor boards
Ashley Love Sumrall shared a post on X/Twitter: "I have praised the work of Shawn…
Nov 22, 2023, 02:53 |
Blog
ESCO is making waves in oncology education! - European School of Oncology
Quoting the European School of Oncology's post on LinkedIn: "ESCO is making waves in oncology…
Nov 22, 2023, 02:47 |
Blog
Lucia Masarova: Let's tackle the inflammation in myelofibrosis! Era of combinational therapies is here
Lucia Masarova, Assistant Professor of the Department of Leukemia at MD Anderson Cancer Center, shared…
Nov 22, 2023, 02:42 |
Blog
Chandler Park: Loved being a part of the ION Oncology Practice Network meeting in Dallas
Chandler Park, Kentucky Physician Representative of the ASCO State Executive Council, shared on LinkedIn: "Loved…
Nov 22, 2023, 02:38 |
Blog
Vivek Subbiah: When JAMA publishes a phase 1 study, it will be a practice-changing study in the future- Lepodisiran
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on…
1
2
All:
19
Posts:
11 - 20
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube